Take it as soon as you remember — unless it is almost time for your next dose, in which case skip the missed one and go back to your normal schedule. Never double up. If your pill has to be taken with food, take the late dose with food too. One late dose is rarely a crisis; long gaps are what matter. Then tell your care team, without apology.
The general rule
NIH's patient drug information says essentially the same thing across the common once-daily regimens: take the missed dose as soon as you remember it; if it is almost time for the next dose, skip the missed dose and continue your regular schedule; and do not take a double dose to make up for a missed one[4]. aidsmap puts it the same way — in most cases, take the missed dose as soon as you realize, then return to your normal schedule[7].
Two practical add-ons. If your pill requires food, the late dose still requires food. And if you vomit within 2 hours of taking your pills — or within 4 hours on a rilpivirine-containing regimen — or you can see pills in the vomit, another dose may be needed, so call your pharmacist or clinic[7].
What your specific regimen says
- Biktarvy (bictegravir/emtricitabine/TAF) — “Take the missed dose as soon as you remember it. Do not take a double dose to make up for a missed one.” Taken with or without food[3]
- Dovato (dolutegravir/lamivudine) — take the missed dose as soon as you remember; if it is almost time for the next dose, skip it and continue your schedule; no double dose. Taken with or without food[4]
- Odefsey (emtricitabine/rilpivirine/TAF) — same missed-dose rule, and the medicine must be taken with food (a meal) once a day, so a late dose needs a meal with it[5]
- Symtuza (darunavir/cobicistat/emtricitabine/TAF) — same missed-dose rule; taken with food once a day[6]
- Long-acting injections (Cabenuva) — different rules entirely. For a planned gap of more than 7 days, daily oral cabotegravir plus rilpivirine can bridge for up to 2 months; unplanned gaps have defined re-initiation rules. Call the clinic rather than waiting[9]
Guidance for a handful of older medicines differs — there is no universal per-drug “how late is too late” table, so ask your pharmacist about your exact pill.
Why one late dose usually isn't a crisis
Modern HIV medicines are more forgiving than the drugs of the 1990s. aidsmap explains that for most newer medicines you do not need to worry about being a bit late, and a single missed dose is rarely the cause of treatment failure — while repeatedly missed doses do raise that risk significantly. Forgiveness comes from a combination of how long a drug stays above its minimal effective concentration and how high its barrier to resistance is. Long-acting injectables are the exception: there, a single missed dose is genuinely concerning[8].
HHS names dolutegravir-, bictegravir-, and boosted darunavir-based regimens as having high genetic barriers to resistance, and specifically recommends them for people who have had difficulty with adherence[1]. What the guidelines deliberately do not do is define a safe number of missed doses: “The minimum level of adherence that is required to prevent sexual transmission has not been determined and may vary depending on the ART regimen and the route of administration”[1]. Anyone relying on treatment as prevention should know that transmission is possible during periods of poor adherence or a treatment interruption[1].
Longer gaps: what actually happens, and how to restart
This is the part worth taking seriously. “Viral rebound typically occurs within days to weeks after ART cessation and has been observed as early as 3 to 6 days after stopping oral ARV medications”[1]. Planned treatment interruptions are not recommended outside a clinical trial (rated AI) because of viral rebound, immune decompensation, and clinical progression, and every effort should be made to keep any unplanned interruption short. For interruptions of less than 1 to 2 days, all drugs in the regimen can simply be held; if someone cannot take anything by mouth, all oral components are stopped together regardless of half-lives and restarted together[2].
And if you have been off treatment and are restarting, the timeline is genuinely encouraging: people who are adherent and have no resistance to their regimen “can generally achieve viral suppression 8 to 12 weeks after ART initiation,” and most people who start treatment reach a viral load under 200 copies/mL within 6 months[1]. Restarting is not starting over.
Missed doses are usually a systems problem — and when to call
The guidelines themselves refuse the shame framing. Adherence “should be assessed and addressed in a constructive and nonjudgmental manner at every clinic visit,” and the suggested wording for clinicians is: “I know it is difficult to take medicine every day. Most people miss doses at least sometimes. Thinking about the last 2 weeks, how many times have you missed doses?” — a format chosen because it “normalizes less-than-perfect adherence”[1]. They go further: engage people struggling with adherence “with a constructive, collaborative, nonjudgmental, and problem-solving approach rather than reprimanding them or lecturing them,” because lecturing “erodes rather than builds the patient–provider relationship, and has been demonstrated to not improve adherence”[1]. If a clinician is lecturing you, the guidelines are on your side.
The barriers HHS names out loud include HIV-related stigma, unstable housing, poverty, food insecurity, transportation, trauma, depression, pill fatigue, privacy concerns, incarceration and reentry, insurance lapses, copays and deductibles, and pharmacy refill problems. Mental illness, substance use disorder, and psychosocial challenges “are not reasons to withhold ART.” The solutions endorsed are equally concrete: simplifying dosing, switching to a better-tolerated or single-tablet regimen, considering long-acting cabotegravir/rilpivirine, flexible or walk-in hours, telehealth, pillboxes and reminders, medication delivery and refill synchronization, transportation help, copay and enrollment assistance, ADAP and Ryan White services, housing and food help, peer navigators, mental-health and substance-use treatment, and trauma-informed care — and combinations work better than any single strategy[1].
Call your care team if: you have missed several doses in a row or run out of medication; you cannot keep pills down; you have been off treatment for more than a couple of days; you are on a long-acting injectable and will miss — or have missed — your appointment window by more than 7 days; or cost, insurance, transportation, or housing is the thing standing between you and your medication[7][2][9]. Do not stretch or split doses to make a supply last.
Florida: if the barrier is access, not memory
HHS names AIDS Drug Assistance Programs and Ryan White HIV/AIDS Program services as adherence interventions in their own right, and tells clinicians to make and review a plan for uninterrupted access to treatment with every person living with HIV[1]. In Florida, that plan has phone numbers: the ADAP Help Desk at 844-381-2327, direct medication services through Prime Therapeutics at 833-604-0925, and enrollment through your county health department. If you do not qualify for ADAP, pharmaceutical patient assistance programs, the Patient Advocate Foundation Co-Pay Relief program, and HarborPath are the next doors to knock on[10].
One gentle Florida-specific note: formulary and income-eligibility rules shifted more than once during 2026 — Florida DOH confirms Biktarvy was restored to the ADAP formulary on July 1, 2026, along with Descovy[10]. If a refill was denied or your coverage changed without warning, you are not imagining it and it is not your fault. Call ADAP or your case manager rather than rationing what you have left.
Related questions
Should I take two pills if I forgot yesterday's dose?
No. NIH's drug information is consistent across regimens: do not take a double dose to make up for a missed one. Take the missed dose as soon as you remember, unless it is almost time for your next dose — in that case skip it and continue your normal schedule.
Will one missed dose make me detectable or cause resistance?
Usually not. Modern medicines are more forgiving, and a single missed dose is rarely the cause of treatment failure, though repeatedly missed doses do raise that risk. Viral rebound has been observed as early as 3 to 6 days after stopping oral antiretrovirals, so it is longer gaps, not one late pill, that matter most.
What if I have been off my medication for weeks?
Call your care team and restart — do not wait until you feel ready. People who are adherent and have no resistance to their regimen can generally achieve viral suppression 8 to 12 weeks after starting, and most reach a viral load under 200 copies/mL within 6 months. Your clinician may check a viral load and consider resistance testing.
Do I have to tell my provider I missed doses?
It helps, and the guidelines are designed so it should not cost you anything. They direct clinicians to assess adherence in a constructive, nonjudgmental way at every visit, using wording that normalizes less-than-perfect adherence — and note that lecturing has been demonstrated to not improve adherence. Honest numbers get you a better regimen, not a scolding.
Related from RiseUpToHIV
References & Sources
- HHS/NIH — Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (adherence section, full PDF). Nonjudgmental adherence assessment language, resistance barriers, viral rebound timing, named barriers and interventions, and suppression timelines. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
- HHS/NIH — Discontinuation or Interruption of Antiretroviral Therapy. Why planned interruptions are not recommended, holding a regimen for short gaps, and stopping or restarting oral components together. ↩ ↩
- NIH MedlinePlus — Bictegravir, Emtricitabine, and Tenofovir Alafenamide (Biktarvy). Verbatim missed-dose instruction and food information for Biktarvy. ↩
- NIH MedlinePlus — Dolutegravir and Lamivudine (Dovato). Missed-dose instruction, including the skip-if-close rule, and food information. ↩ ↩
- NIH MedlinePlus — Emtricitabine, Rilpivirine, and Tenofovir Alafenamide (Odefsey). Missed-dose instruction plus the requirement to take Odefsey with a meal. ↩
- NIH MedlinePlus — Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (Symtuza). Missed-dose instruction and the with-food requirement for Symtuza. ↩
- aidsmap — Adherence to HIV treatment. General missed-dose rule, the vomiting-within-2-hours (4 hours with rilpivirine) guidance, and reasons to contact a clinic. ↩ ↩ ↩
- aidsmap — What happens to HIV drugs in the body, and do missed doses matter?. How drug forgiveness works, why one late dose rarely causes failure, and why long-acting injectables are the exception. ↩
- FDA — Cabenuva prescribing information (missed-injection management). Oral bridging for planned gaps and re-initiation rules for unplanned gaps in long-acting therapy. ↩ ↩
- Florida Department of Health — AIDS Drug Assistance Program. ADAP Help Desk and Prime Therapeutics numbers, alternative assistance programs, and the July 1, 2026 Biktarvy restoration. ↩ ↩
Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.